Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1650324Generated: November 1, 2026

HCID 10006646, compound → 5-Amino-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol

https://huagongshe.com/reaction/1650324

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHCID 10006646HCID 10006646—
CatalystPlatinum oxide (PtO)HCID 82844—
Product5-Amino-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrolHCID 17431227.6%

Reaction Steps

An aqueous solution (30 mL) of validamycin G (106 mg) was submitted to catalytic reduction at room temperature under atmospheric pressure in the presence of platinum oxide (10 mg). The catalyst was removed by filtration and the filtrate was adsorbed onto a column of Amberlite CG-50 (NH4+ form, 30 mL) followed by washing with water and then elution with 0.5N aqueous ammonia. The eluate was concentrated to dryness under reduced pressure, and the residue was dissolved in 1N sulfuric acid (20 mL) and hydrolyzed at 80° C. for 10 hours. The reaction mixture was neutralized with barium hydroxide and the supernatant obtained by centrifugation was concentrated under reduced pressure. The concentrate was adsorbed onto a column of Amberlite CG-50 (ammonium form, 20 mL) followed by washing with water and then elution with 0.5N aqueous ammonia. The eluate was concentrated under reduced pressure and submitted to column chromatography on Dowex 1×2 (OH- form, 100 mL) followed by elution with water. The eluate fractions were concentrated under reduced pressure and then freeze-dried, to give a white powder of valiolamine (11 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04923975
Source datasetuspto-grants-1990_05
ORD IDord-7d95aec210b940f99605d448fcbff843
Source noteuspto-grants-1990_05